Cargando…

Randomized, Placebo-Controlled Prospective Clinical Trial Evaluating the Efficacy of the Assisi Anti-anxiety Device (Calmer Canine) for the Treatment of Canine Separation Anxiety

Introduction: Separation anxiety (SA) is among the most common canine behavior disorders and affects quality-of-life for dogs and their owners. Dogs with SA show signs of anxiety during absence or perceived absence of their owners. While psychoactive medications are often helpful for treating SA, do...

Descripción completa

Detalles Bibliográficos
Autores principales: Pankratz, Katherine, Korman, Judy, Emke, Carrie, Johnson, Brianna, Griffith, Emily H., Gruen, Margaret E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8720769/
https://www.ncbi.nlm.nih.gov/pubmed/34988140
http://dx.doi.org/10.3389/fvets.2021.775092
_version_ 1784625194527096832
author Pankratz, Katherine
Korman, Judy
Emke, Carrie
Johnson, Brianna
Griffith, Emily H.
Gruen, Margaret E.
author_facet Pankratz, Katherine
Korman, Judy
Emke, Carrie
Johnson, Brianna
Griffith, Emily H.
Gruen, Margaret E.
author_sort Pankratz, Katherine
collection PubMed
description Introduction: Separation anxiety (SA) is among the most common canine behavior disorders and affects quality-of-life for dogs and their owners. Dogs with SA show signs of anxiety during absence or perceived absence of their owners. While psychoactive medications are often helpful for treating SA, dog and human factors may limit their utility. This study explored the efficacy of a pulsed electromagnetic field (PEMF) device for treatment of canine SA. Materials and Methods: In this double-blind randomized placebo-controlled study, a screening questionnaire and baseline video confirmed the diagnosis of SA. Owners treated their dog with the device twice daily for 6 weeks, completed weekly questionnaires, and noted adverse events. Videos were taken of the dog while alone at weeks 4 and 6. Behaviors were coded and categorized as negative and positive. Questionnaire and video data at weeks 4 and 6 were compared to baseline. Results: Forty client-owned dogs with moderate to severe SA completed the study. There were no differences between groups for age, weight, or sex. In owner questionnaires, no difference in behavior or overall score was found between the active and sham groups (p > 0.05). Videos of the active group compared to the sham group showed significant reduction in negative behaviors by week 6 (p = 0.036) and higher percentage of success at week 4 (Z = 2.83, p = 0.005), at week 6 (Z = 1.65, p = 0.098), and across the full study (Z = 1.99, p = 0.047). Adverse events were reported in eight dogs (6 active, 2 sham); all resolved and were unlikely to be related to treatment. Discussion: This study supports the efficacy and safety of this PEMF device for treatment of SA in dogs. Questionnaire results may not be sensitive enough to detect subtle negative behavioral states compared to video, and may not capture other owner observed behavioral changes. A caregiver placebo effect may account for some improvement seen in both groups. Video data appear better for diagnosis and monitoring dog's behavior when left alone. Future studies should assess PEMF's impact on other anxieties or combination of anxiety disorders in dogs.
format Online
Article
Text
id pubmed-8720769
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-87207692022-01-04 Randomized, Placebo-Controlled Prospective Clinical Trial Evaluating the Efficacy of the Assisi Anti-anxiety Device (Calmer Canine) for the Treatment of Canine Separation Anxiety Pankratz, Katherine Korman, Judy Emke, Carrie Johnson, Brianna Griffith, Emily H. Gruen, Margaret E. Front Vet Sci Veterinary Science Introduction: Separation anxiety (SA) is among the most common canine behavior disorders and affects quality-of-life for dogs and their owners. Dogs with SA show signs of anxiety during absence or perceived absence of their owners. While psychoactive medications are often helpful for treating SA, dog and human factors may limit their utility. This study explored the efficacy of a pulsed electromagnetic field (PEMF) device for treatment of canine SA. Materials and Methods: In this double-blind randomized placebo-controlled study, a screening questionnaire and baseline video confirmed the diagnosis of SA. Owners treated their dog with the device twice daily for 6 weeks, completed weekly questionnaires, and noted adverse events. Videos were taken of the dog while alone at weeks 4 and 6. Behaviors were coded and categorized as negative and positive. Questionnaire and video data at weeks 4 and 6 were compared to baseline. Results: Forty client-owned dogs with moderate to severe SA completed the study. There were no differences between groups for age, weight, or sex. In owner questionnaires, no difference in behavior or overall score was found between the active and sham groups (p > 0.05). Videos of the active group compared to the sham group showed significant reduction in negative behaviors by week 6 (p = 0.036) and higher percentage of success at week 4 (Z = 2.83, p = 0.005), at week 6 (Z = 1.65, p = 0.098), and across the full study (Z = 1.99, p = 0.047). Adverse events were reported in eight dogs (6 active, 2 sham); all resolved and were unlikely to be related to treatment. Discussion: This study supports the efficacy and safety of this PEMF device for treatment of SA in dogs. Questionnaire results may not be sensitive enough to detect subtle negative behavioral states compared to video, and may not capture other owner observed behavioral changes. A caregiver placebo effect may account for some improvement seen in both groups. Video data appear better for diagnosis and monitoring dog's behavior when left alone. Future studies should assess PEMF's impact on other anxieties or combination of anxiety disorders in dogs. Frontiers Media S.A. 2021-12-20 /pmc/articles/PMC8720769/ /pubmed/34988140 http://dx.doi.org/10.3389/fvets.2021.775092 Text en Copyright © 2021 Pankratz, Korman, Emke, Johnson, Griffith and Gruen. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Veterinary Science
Pankratz, Katherine
Korman, Judy
Emke, Carrie
Johnson, Brianna
Griffith, Emily H.
Gruen, Margaret E.
Randomized, Placebo-Controlled Prospective Clinical Trial Evaluating the Efficacy of the Assisi Anti-anxiety Device (Calmer Canine) for the Treatment of Canine Separation Anxiety
title Randomized, Placebo-Controlled Prospective Clinical Trial Evaluating the Efficacy of the Assisi Anti-anxiety Device (Calmer Canine) for the Treatment of Canine Separation Anxiety
title_full Randomized, Placebo-Controlled Prospective Clinical Trial Evaluating the Efficacy of the Assisi Anti-anxiety Device (Calmer Canine) for the Treatment of Canine Separation Anxiety
title_fullStr Randomized, Placebo-Controlled Prospective Clinical Trial Evaluating the Efficacy of the Assisi Anti-anxiety Device (Calmer Canine) for the Treatment of Canine Separation Anxiety
title_full_unstemmed Randomized, Placebo-Controlled Prospective Clinical Trial Evaluating the Efficacy of the Assisi Anti-anxiety Device (Calmer Canine) for the Treatment of Canine Separation Anxiety
title_short Randomized, Placebo-Controlled Prospective Clinical Trial Evaluating the Efficacy of the Assisi Anti-anxiety Device (Calmer Canine) for the Treatment of Canine Separation Anxiety
title_sort randomized, placebo-controlled prospective clinical trial evaluating the efficacy of the assisi anti-anxiety device (calmer canine) for the treatment of canine separation anxiety
topic Veterinary Science
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8720769/
https://www.ncbi.nlm.nih.gov/pubmed/34988140
http://dx.doi.org/10.3389/fvets.2021.775092
work_keys_str_mv AT pankratzkatherine randomizedplacebocontrolledprospectiveclinicaltrialevaluatingtheefficacyoftheassisiantianxietydevicecalmercanineforthetreatmentofcanineseparationanxiety
AT kormanjudy randomizedplacebocontrolledprospectiveclinicaltrialevaluatingtheefficacyoftheassisiantianxietydevicecalmercanineforthetreatmentofcanineseparationanxiety
AT emkecarrie randomizedplacebocontrolledprospectiveclinicaltrialevaluatingtheefficacyoftheassisiantianxietydevicecalmercanineforthetreatmentofcanineseparationanxiety
AT johnsonbrianna randomizedplacebocontrolledprospectiveclinicaltrialevaluatingtheefficacyoftheassisiantianxietydevicecalmercanineforthetreatmentofcanineseparationanxiety
AT griffithemilyh randomizedplacebocontrolledprospectiveclinicaltrialevaluatingtheefficacyoftheassisiantianxietydevicecalmercanineforthetreatmentofcanineseparationanxiety
AT gruenmargarete randomizedplacebocontrolledprospectiveclinicaltrialevaluatingtheefficacyoftheassisiantianxietydevicecalmercanineforthetreatmentofcanineseparationanxiety